查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1570844

抗凝血酵素III 測試市場：按產品類型、技術、應用和最終用戶分類 - 2025-2030 年全球預測

Anti-Thrombin III Testing Market by Product Type (Cardiac Test Kits, ELISA Test Kits, FIA Test Kits), Technology (Chromogenic Assay, Immunoassay), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年抗凝血酵素III檢測市值為9,143萬美元，預計2024年將達9,984萬美元，複合年成長率為9.39%，預計到2030年將達到17,137萬美元。

抗凝血酵素III 檢測在醫學領域至關重要，因為它在血栓性疾病的診斷和治療以及確保抗凝血治療的有效性方面發揮著重要作用。對此測試的需求是由於其在檢測導致血栓症形成風險增加的先天性或後天性抗凝血酵素III 缺陷中的應用。其應用涵蓋醫院實驗室、診斷中心和研究機構等醫療保健環境，擁有主要最終用戶。市場成長受到血栓栓塞性疾病發病率上升、診斷技術進步以及更容易患凝血疾病的老年人數量增加的影響。人們對凝血障礙的認知不斷提高，需求也進一步增加。最近，技術進步帶來了潛在的機遇，這些進步促進了照護現場診斷工具和人工智慧的整合，以提高準確性和效率。公司可以透過投資研究合作夥伴關係並利用最尖端科技增強產品系列來利用這些機會。然而，市場成長面臨嚴格的監管要求、高昂的測試成本以及需要熟練的專業人員執行測試和準確解釋結果等挑戰。這些限制可能會阻礙採用，特別是在低收入地區。創新和研究應著重於增強非侵入性檢測方法、降低成本並利用數位技術確保更容易獲得和簡化診斷。強調個人化醫療方法並開發強大的預測模型將為業務成長開闢新的途徑。這個市場本​​質上是協作性的，與醫院、診斷服務供應商和學術研究機構的夥伴關係可以推動創新。總體而言，市場格局是動態的，儘管存在挑戰，但技術創新和策略市場參與的整合可以提供重大的成長機會。

主要市場統計
基準年[2023] 9143萬美元
預測年份 [2024] 9984萬美元
預測年份 [2030] 17137萬美元
複合年成長率（%） 9.39%

市場動態：揭示快速發展的抗凝血酵素III 測試市場的關鍵市場洞察

抗凝血酵素III 檢測市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，以及消費行為及其對製造業的影響，您還可以更清楚地了解其對成本和採購趨勢的影響。

波特五力：駕馭抗凝血酵素III 測試市場的策略工具

波特五力框架是了解抗凝血酵素III 測試市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解抗凝血酵素III 檢測市場的外部影響

外部宏觀環境因素在塑造抗凝血酵素III 測試市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解抗凝血酵素III 檢測市場的競爭格局

抗凝血酵素III 測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣抗凝血酵素III 測試市場供應商的績效評估

FPNV 定位矩陣是評估抗凝血酵素III 測試市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃抗凝血酵素III 測試市場的成功之路

抗凝血酵素III 測試市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

該報告提供了涵蓋關鍵焦點細分市場的全面市場分析。

1. 市場滲透率：對當前市場環境的詳細回顧。

2. 市場開拓：辨識新興市場的成長機會，評估現有產業的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢視市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 需要抗凝血酶 III 監測以改善手術全期護理的外科手術數量增加
      • 越來越多的老年人需要定期預防血栓症
      • 擴大新興國家的醫療基礎設施
    • 抑制因素
      • 擅長抗凝血酵素III 檢測的專家和專業實驗室數量有限
    • 機會
      • 擴大心血管醫療機構的抗凝血酵素III 檢測服務
      • 與生技公司合作創新新的抗凝血酵素III 測試方法
    • 任務
      • 監管合規性和嚴格的指導方針
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章抗凝血酵素III 檢測市場：依產品類型

  • 介紹
  • 心臟檢測套組
  • ELISA檢測套組
  • 國際汽聯測試套件

第7章抗凝血酵素III 檢測市場：依技術分類

  • 介紹
  • 比色測定
  • 免疫檢測

第8章抗凝血酵素III 檢測市場：依應用分類

  • 介紹
  • 診斷實驗室
    • 醫院實驗室
    • 獨立診斷實驗室
  • 就地檢驗
  • 研究/學術機構
    • 臨床研究單位
    • 大學/短期大學

第 9 章抗凝血酵素III 檢驗市場：依最終使用者分類

  • 介紹
  • 門診手術中心
  • 診斷實驗室
  • 醫院
  • 專科診所

第10章美洲抗凝血酵素III檢測市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區抗凝血酵素III檢測市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲抗凝血酵素III檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C0463

The Anti-Thrombin III Testing Market was valued at USD 91.43 million in 2023, expected to reach USD 99.84 million in 2024, and is projected to grow at a CAGR of 9.39%, to USD 171.37 million by 2030.

Anti-Thrombin III Testing is essential in the medical field as it plays a crucial role in diagnosing and managing thrombotic disorders and ensuring the efficacy of anticoagulant therapies. The necessity of this testing is driven by its application in detecting congenital or acquired deficiencies in Anti-Thrombin III, which can lead to an increased risk of thrombosis. Its applications span across healthcare settings such as hospital laboratories, diagnostic centers, and research institutions, which serve as the primary end-users. Market growth is influenced by rising incidences of thromboembolic disorders, advancements in diagnostic technologies, and an increasing elderly population prone to blood clotting disorders. The growing awareness about coagulation disorders further amplifies the demand. Recently, potential opportunities have arisen from technological advancements that facilitate point-of-care diagnostic tools and the integration of Artificial Intelligence for improved accuracy and efficiency. Companies can capitalize on these opportunities by investing in research partnerships and enhancing their product portfolios with cutting-edge technologies. However, market growth faces challenges such as stringent regulatory requirements, high testing costs, and the need for skilled professionals to conduct and interpret results accurately. These limitations could hinder widespread adoption, particularly in low-income regions. Innovation and research should focus on enhancing non-invasive testing methods, reducing costs, and leveraging digital technologies to ensure easier access and streamlined diagnostics. Emphasizing personalized medicine approaches and developing robust predictive models can open new avenues for business growth. The market is inherently collaborative, where partnerships with hospitals, diagnostic service providers, and academic research bodies could propel innovation. Overall, the Anti-Thrombin III Testing market presents a dynamic landscape where the amalgamation of technological innovation and strategic market engagements can offer substantial growth opportunities despite existing challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 91.43 million
Estimated Year [2024] USD 99.84 million
Forecast Year [2030] USD 171.37 million
CAGR (%) 9.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anti-Thrombin III Testing Market

The Anti-Thrombin III Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of surgical procedures requiring anti-thrombin III monitoring for better perioperative care
    • Increase in geriatric population prone to thrombotic disorders necessitating regular anti-thrombin III testing
    • Expansion of healthcare infrastructure in emerging economies
  • Market Restraints
    • Limited availability of skilled professionals and specialized laboratories for anti-thrombin III testing
  • Market Opportunities
    • Expansion of anti-thrombin III testing services in specialized cardiovascular care facilities
    • Collaborations with biotechnology firms to innovate new anti-thrombin III testing methodologies
  • Market Challenges
    • Regulatory compliance and stringent guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Anti-Thrombin III Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anti-Thrombin III Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anti-Thrombin III Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anti-Thrombin III Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anti-Thrombin III Testing Market

A detailed market share analysis in the Anti-Thrombin III Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anti-Thrombin III Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anti-Thrombin III Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anti-Thrombin III Testing Market

A strategic analysis of the Anti-Thrombin III Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anti-Thrombin III Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories, bioMerieux, Chrono-log Corporation, Danaher Corporation, DiaSorin, Grifols, Immucor, Instrumentation Laboratory, Merck KGaA, PerkinElmer, Quidel Corporation, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, and Werfen.

Market Segmentation & Coverage

This research report categorizes the Anti-Thrombin III Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cardiac Test Kits, ELISA Test Kits, and FIA Test Kits.
  • Based on Technology, market is studied across Chromogenic Assay and Immunoassay.
  • Based on Application, market is studied across Diagnostic Laboratories, Point of Care Testing, and Research and Academic Institutes. The Diagnostic Laboratories is further studied across Hospital Laboratories and Independent Diagnostics Laboratories. The Research and Academic Institutes is further studied across Clinical Research Units and Universities & Colleges.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of surgical procedures requiring anti-thrombin III monitoring for better perioperative care
      • 5.1.1.2. Increase in geriatric population prone to thrombotic disorders necessitating regular anti-thrombin III testing
      • 5.1.1.3. Expansion of healthcare infrastructure in emerging economies
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals and specialized laboratories for anti-thrombin III testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of anti-thrombin III testing services in specialized cardiovascular care facilities
      • 5.1.3.2. Collaborations with biotechnology firms to innovate new anti-thrombin III testing methodologies
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory compliance and stringent guidelines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anti-Thrombin III Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cardiac Test Kits
  • 6.3. ELISA Test Kits
  • 6.4. FIA Test Kits

7. Anti-Thrombin III Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Chromogenic Assay
  • 7.3. Immunoassay

8. Anti-Thrombin III Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
    • 8.2.1. Hospital Laboratories
    • 8.2.2. Independent Diagnostics Laboratories
  • 8.3. Point of Care Testing
  • 8.4. Research and Academic Institutes
    • 8.4.1. Clinical Research Units
    • 8.4.2. Universities & Colleges

9. Anti-Thrombin III Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Diagnostic Laboratories
  • 9.4. Hospitals
  • 9.5. Specialty Clinics

10. Americas Anti-Thrombin III Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Anti-Thrombin III Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Anti-Thrombin III Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories
  • 5. bioMerieux
  • 6. Chrono-log Corporation
  • 7. Danaher Corporation
  • 8. DiaSorin
  • 9. Grifols
  • 10. Immucor
  • 11. Instrumentation Laboratory
  • 12. Merck KGaA
  • 13. PerkinElmer
  • 14. Quidel Corporation
  • 15. Roche Diagnostics
  • 16. Sekisui Diagnostics
  • 17. Siemens Healthineers
  • 18. Sysmex Corporation
  • 19. Thermo Fisher Scientific
  • 20. Werfen

LIST OF FIGURES

  • FIGURE 1. ANTI-THROMBIN III TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ANTI-THROMBIN III TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ANTI-THROMBIN III TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ANTI-THROMBIN III TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTI-THROMBIN III TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTI-THROMBIN III TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CARDIAC TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ELISA TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY FIA TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CHROMOGENIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INDEPENDENT DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL RESEARCH UNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY UNIVERSITIES & COLLEGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. ANTI-THROMBIN III TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. ANTI-THROMBIN III TESTING MARKET, FPNV POSITIONING MATRIX, 2023